Stay updated on Pembrolizumab Combo in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page.
Latest updates to the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page
- Check2 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe website has been updated to version 2.14.1 on January 13, 2025, following the removal of version 2.14.0 on November 19, 2024.SummaryDifference1%
- Check24 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.9%
- Check53 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check60 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check74 days agoChange DetectedOn November 19, 2024, new content was added, while on November 7, 2024, a significant section detailing data download options and study information fields was removed.SummaryDifference13%
Stay in the know with updates to Pembrolizumab Combo in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page.